Publications by authors named "Jamie Robyn"

Claim this Profile
C
Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.
Todd M Wilson, Irina Maric, Olga Simakova, Yun Bai, Eunice Ching Chan, Jamie Robyn

Haematologica· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic mastocytosis.
Jamie Robyn, Dean D Metcalfe

Adv Immunol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.
Idoya Lahortiga, Cem Akin, Jan Cools, Todd M Wilson, Nicole Mentens, Jamie Robyn

Haematologica· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
Amy D Klion, Jamie Robyn, Irina Maric, Weiming Fu, Laura Schmid

Blood· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.
Irina Maric, Jamie Robyn, Dean D Metcalfe, Michael P Fay, Melody Carter

J Allergy Clin Immunol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.
Melody C Carter, Jamie A Robyn, Peter B Bressler, John C Walker, Gail G Shapiro

J Allergy Clin Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib-responsive hypereosinophilic syndrome.
Jamie Robyn

Leuk Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of systemic mastocytosis.
Todd M Wilson, Dean D Metcalfe, Jamie Robyn

Immunol Allergy Clin North Am· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome.
Jamie Robyn, Steven Lemery, J Philip McCoy, Joseph Kubofcik, Yae-Jean Kim

Br J Haematol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib-responsive hypereosinophilia in a patient with B cell ALL.
Jamie Robyn, Pierre Noel, Iwona Wlodarska, Mamta Choksi, Patricia O'neal

Leuk Lymphoma· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.
Amy D Klion, Jamie Robyn, Cem Akin, Pierre Noel, Margaret Brown

Blood· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, Jamie Robyn, Fausto Loberiza

Blood· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis